Publication | Closed Access

Structural optimization of 4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-[1,2,4]triazolo[4,3-a][1,4]diazepines as antagonists for platelet activating factor: pharmacological contribution of substituents at the 2- and 6-positions of a condensed ring system

EngineeringRing SystemMedicineDrug DiscoveryMechanism Of ActionPharmacological ContributionPharmacotherapyStructural OptimizationHeterocycle ChemistryPharmacologyBiomolecular Engineering